It's been a mediocre week for Omnicell, Inc. (NASDAQ:OMCL) shareholders, with the stock dropping 19% to US$25.39 in the week since its latest quarterly results. The results don't look great, ...

Ratings for Omnicell (NASDAQ:OMCL) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table encapsulates their recent ratings ...

Ratings for Omnicell OMCL were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table encapsulates their recent ratings ...

Omnicell Inc. (OMCL) reported its first-quarter 2025 earnings, exceeding Wall Street’s expectations with an earnings per share (EPS) of $0.26, surpassing the forecasted $0.21. Despite this positive ...

CEO Randall Lipps highlighted strong Q1 2025 performance driven by demand for Omnicell's medication management platform. Key focus areas included market share growth in inpatient and outpatient ...

Omnicell shares fell after the company lowered its guidance due to expected costs and uncertainty from tariffs. The stock slid 15% to $26.01 on Tuesday morning, at one point touching a 52-week low ...

Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q1 CY2025 results topping the market’s revenue expectations , with sales up 9.6% year on year to $269.7 million. On the other hand, next quarter ...

Updates full year 2025 non-GAAP EBITDA and non-GAAP EPS guidance FORT WORTH, Texas, May 06, 2025--(BUSINESS WIRE)--Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell," "we ...

FORT WORTH, Texas (AP) — FORT WORTH, Texas (AP) — Omnicell Inc. (OMCL) on Tuesday reported a loss of $7 million in its first quarter. On a per-share basis, the Fort Worth, Texas-based company ...